FREQUENT CHEST-X-RAY FLUOROSCOPY AND BREAST-CANCER INCIDENCE AMONG TUBERCULOSIS PATIENTS IN MASSACHUSETTS

被引:240
作者
BOICE, JD
PRESTON, D
DAVIS, FG
MONSON, RR
机构
[1] RADIAT EFFECTS RES FDN, DEPT STAT, HIROSHIMA 730, JAPAN
[2] UNIV ILLINOIS, SCH PUBL HLTH, EPIDEMIOL & BIOSTAT PROGRAM, CHICAGO, IL 60680 USA
[3] HARVARD UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, BOSTON, MA 02115 USA
关键词
D O I
10.2307/3577890
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The incidence of breast cancer was determined in 4940 women treated for tuberculosis between 1925 and 1954 in Massachusetts. Among 2573 women examined by X-ray fluoroscopy an average of 88 times during lung collapse therapy and followed for an average of 30 years, 147 breast cancers occurred in contrast to 113.6 expected [observed/expected (O/E) = 1.29; 95% confidence interval (CI) = 1.1-1.5]. No excess of breast cancer was seen among 2367 women treated by other means: 87 observed versus 100.9 expected. Increased rates for breast cancer were not apparent until about 10 to 15 years after the initial fluoroscopy examination. Excess risk then remained high throughout all intervals of follow-up, up to 50 years after first exposure. Age at exposure strongly influenced the risk of radiation-induced breast cancer with young women being at highest risk and those over age 40 being at lowest risk [relative risk (RR) = 1.06]. Mean radiation dose to the breast was estimated to be 79 cGy, and there was strong evidence for a linear relationship between dose and breast cancer risk. Allowing for a 10-year minimum latent period, the relative risk at 1 Gy was estimated as 1.61 and the absolute excess as 10.7 per 104 woman-years per gray. When compared to other studies, our data suggest that the breast is one of the most sensitive tissues to the carcinogenic force of radiation, that fractionated exposures are similar to single exposures of the same total dose in their ability to induce breast cancer, that risk remains high for many years after exposure, and that young women are especially vulnerable to radiation injury.
引用
收藏
页码:214 / 222
页数:9
相关论文
共 51 条
[1]   MAMMOGRAPHY BEFORE AGE 50 YEARS [J].
BAILAR, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (10) :1548-1549
[2]  
BARAL E, 1977, CANCER, V40, P2905, DOI 10.1002/1097-0142(197712)40:6<2905::AID-CNCR2820400621>3.0.CO
[3]  
2-Y
[4]   RISK OF BREAST-CANCER FOLLOWING LOW-DOSE RADIATION EXPOSURE [J].
BOICE, JD ;
LAND, CE ;
SHORE, RE ;
NORMAN, JE ;
TOKUNAGA, M .
RADIOLOGY, 1979, 131 (03) :589-597
[5]   RADIATION-DOSE AND BREAST-CANCER RISK IN PATIENTS TREATED FOR CANCER OF THE CERVIX [J].
BOICE, JD ;
BLETTNER, M ;
KLEINERMAN, RA ;
ENGHOLM, G ;
STOVALL, M ;
LISCO, H ;
AUSTIN, DF ;
BOSCH, A ;
HARLAN, L ;
KREMENTZ, ET ;
LATOURETTE, HB ;
MERRILL, JA ;
PETERS, LJ ;
SCHULZ, MD ;
WACTAWSKI, J ;
STORM, HH ;
BJORKHOLM, E ;
PETTERSSON, F ;
BELL, CMJ ;
COLEMAN, MP ;
FRASER, P ;
NEAL, FE ;
PRIOR, P ;
CHOI, NW ;
HISLOP, TG ;
KOCH, M ;
KREIGER, N ;
ROBB, D ;
ROBSON, D ;
THOMSON, DH ;
LOCHMULLER, H ;
VONFOURNIER, D ;
FRISCHKORN, R ;
KJORSTAD, KE ;
RIMPELA, A ;
PEJOVIC, MH ;
KIRN, VP ;
STANKUSOVA, H ;
PISANI, P ;
SIGURDSSON, K ;
HUTCHISON, GB ;
MACMAHON, B .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) :7-16
[6]  
BOICE JD, 1985, J NATL CANCER I, V74, P955
[7]   FOLLOW-UP METHODS TO TRACE WOMEN TREATED FOR PULMONARY TUBERCULOSIS, 1930-1954 [J].
BOICE, JD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1978, 107 (02) :127-139
[8]   ESTIMATION OF BREAST DOSES AND BREAST-CANCER RISK ASSOCIATED WITH REPEATED FLUOROSCOPIC CHEST EXAMINATIONS OF WOMEN WITH TUBERCULOSIS [J].
BOICE, JD ;
ROSENSTEIN, M ;
TROUT, ED .
RADIATION RESEARCH, 1978, 73 (02) :373-390
[9]   BREAST-CANCER IN WOMEN AFTER REPEATED FLUOROSCOPIC EXAMINATIONS OF CHEST [J].
BOICE, JD ;
MONSON, RR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (03) :823-832
[10]   FINAL REPORTS OF NATIONAL-CANCER-INSTITUTE AD HOC WORKING GROUPS ON MAMMOGRAPHY IN SCREENING FOR BREAST-CANCER AND A SUMMARY REPORT OF THEIR JOINT FINDINGS AND RECOMMENDATIONS [J].
BRESLOW, L ;
THOMAS, LB ;
UPTON, AC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (02) :467-541